-
NOF to Exhibit at ARVO 2026 from May 3 – 6
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming ARVO 2026 Annual Meeting(*1) to be held at the Colorado Convention Center, Denver, CO, USA from May 3 to 7.
At the event, NOF CORPORATION will highlight its YT-LIPIDURE® series, a major product line for eye drops, at booth #5030 from May 3 to May 6.
NOF CORPORATION invites attendees to visit booth #5030 to explore the innovative solutions, to engage with their experts, and to discuss potential collaborations.
For further information or to arrange a meeting, please refer to the contact form.
* Please select “Life Science” for the Business division field.
Product Highlights:
YT-LIPIDURE® series
YT-LIPIDURE® is a series of MPC(*2)-based polymers designed to enhance eye drop formulations with multi-functional benefits.
YT-LIPIDURE® is a PMDA(*3)-approved additive in Japan, compatible with both hard and soft contact lenses.- Long-lasting moisturization
- Reduces dry eye discomfort.
- Stabilizes the tear film and prevents breakup
- Protective effect against preservatives
*1 ARVO: Association for Research in Vision and Ophthalmology
*2 MPC: 2-Methacryloyloxyethyl phosphorylcholine
*3 PMDA: Pharmaceuticals and Medical Devices Agency
